top of page

ADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML

Product details

Registration number: SIN17460P

Classification: Prescription Only

Active ingredients:

  • (Acellular Pertussis) FilamentousHaemagglutinin Adsorbed (FHA)
  • (Acellular Pertussis) Fimbriae Type 2 and 3Adsorbed (FIM)
  • (Acellular Pertussis) Pertactin Adsorbed (PRN)
  • (Acelullar Pertussis) Pertussis ToxoidAdsorbed (PT)
  • Diphtheria Toxoid Adsorbed
  • Tetanus Toxoid Adsorbed

Strength:

  • 5 μg/ 0.5mL
  • 5 μg/ 0.5mL
  • 3 μg/ 0.5mL
  • 2.5 μg/ 0.5mL
  • 2 LF/ 0.5mL
  • 5 LF/ 0.5mL

Dosage form: INJECTION, SUSPENSION

Route: INTRAMUSCULAR

Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.

ATC code: J07AJ52

HSA approval date: 9 February 2026

Manufacturer(s): Sanofi Pasteur Limited

Manufacturing country/countries: CANADA

What are the HSA registration number and classification for ADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN17460P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for ADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • (Acellular Pertussis) FilamentousHaemagglutinin Adsorbed (FHA)
  • (Acellular Pertussis) Fimbriae Type 2 and 3Adsorbed (FIM)
  • (Acellular Pertussis) Pertactin Adsorbed (PRN)
  • (Acelullar Pertussis) Pertussis ToxoidAdsorbed (PT)
  • Diphtheria Toxoid Adsorbed
  • Tetanus Toxoid Adsorbed

Strength:

  • 5 μg/ 0.5mL
  • 5 μg/ 0.5mL
  • 3 μg/ 0.5mL
  • 2.5 μg/ 0.5mL
  • 2 LF/ 0.5mL
  • 5 LF/ 0.5mL

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for ADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SUSPENSION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for ADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML?

According to the HSA dataset updated 7 August 2026:

Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for ADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Sanofi Pasteur Limited

Manufacturing country/countries: CANADA

Source for this answer

Where can I look up ADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN17460P or the exact product name ADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML. The general register link does not preselect this product.

Source for this answer

What are the source dates for this ADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this ADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN17460P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page